Bar Harbor Wealth Management reduced its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 3.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 131,692 shares of the company’s stock after selling 4,370 shares during the quarter. Bar Harbor Wealth Management’s holdings in Colgate-Palmolive were worth $11,972,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also bought and sold shares of the company. Sivia Capital Partners LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $228,000. Wedmont Private Capital lifted its holdings in Colgate-Palmolive by 53.1% in the fourth quarter. Wedmont Private Capital now owns 12,391 shares of the company’s stock worth $1,070,000 after buying an additional 4,295 shares during the period. Capital Investment Advisors LLC boosted its position in shares of Colgate-Palmolive by 2.5% during the fourth quarter. Capital Investment Advisors LLC now owns 9,634 shares of the company’s stock valued at $876,000 after purchasing an additional 238 shares in the last quarter. Brookstone Capital Management boosted its stake in Colgate-Palmolive by 12.0% during the fourth quarter. Brookstone Capital Management now owns 19,455 shares of the company’s stock worth $1,769,000 after acquiring an additional 2,089 shares in the last quarter. Finally, Trust Co. of Toledo NA OH increased its stake in shares of Colgate-Palmolive by 3.8% during the fourth quarter. Trust Co. of Toledo NA OH now owns 18,096 shares of the company’s stock valued at $1,645,000 after purchasing an additional 663 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
CL has been the topic of a number of analyst reports. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday. JPMorgan Chase & Co. raised their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Wells Fargo & Company lowered their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. TD Cowen reduced their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Finally, Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price target for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $103.63.
Colgate-Palmolive Stock Up 0.8 %
Shares of Colgate-Palmolive stock traded up $0.66 during trading on Monday, hitting $87.02. 5,920,014 shares of the stock traded hands, compared to its average volume of 4,886,583. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The stock’s fifty day simple moving average is $92.62 and its 200 day simple moving average is $98.06. The firm has a market cap of $71.10 billion, a P/E ratio of 24.93, a price-to-earnings-growth ratio of 3.31 and a beta of 0.44. Colgate-Palmolive has a 52-week low of $79.69 and a 52-week high of $109.30.
Colgate-Palmolive Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.30%. Colgate-Palmolive’s payout ratio is presently 57.31%.
Insider Activity
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.34% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- About the Markup Calculator
- Delta Can Fly to New Highs in 2025; Here’s Why
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Snowflake Stock: Bullish Upgrades Demand Investors’ Attention
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.